BioAtla, Inc.
BCAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28,717 | $117,533 | $321,150 | $678,437 |
| - Cash | $49,046 | $111,471 | $215,507 | $244,979 |
| + Debt | $836 | $2,460 | $3,981 | $5,371 |
| Enterprise Value | -$19,493 | $8,522 | $109,624 | $438,829 |
| Revenue | $11,000 | $0 | $0 | $250 |
| % Growth | – | – | -100% | – |
| Gross Profit | $10,075 | -$1,221 | -$1,199 | $250 |
| % Margin | 91.6% | – | – | 100% |
| EBITDA | -$73,018 | -$122,241 | -$105,283 | -$94,069 |
| % Margin | -663.8% | – | – | -37,627.6% |
| Net Income | -$69,776 | -$123,462 | -$105,283 | -$95,402 |
| % Margin | -634.3% | – | – | -38,160.8% |
| EPS Diluted | -1.44 | -2.58 | -2.74 | -2.76 |
| % Growth | 44.2% | 5.8% | 0.7% | – |
| Operating Cash Flow | -$71,936 | -$104,015 | -$90,420 | -$62,214 |
| Capital Expenditures | $0 | -$98 | -$268 | -$924 |
| Free Cash Flow | -$71,936 | -$104,113 | -$90,688 | -$63,138 |